"Let food be your medicine, and let medicine be your food" Hippocrates (^^ - 500BC)
|
Nutri Pharma ASAKronprinsesse Marthas
Plass 1 P.O Box 1477, Vika N-0116 Oslo Norway Telephone +47 23 01 09 60 Telefax +47 23 01 09 70 Send e-mail |
Press RoomNutri Pharmas’s information policy aims at a regular contact with the various stakeholders of the company. Emphasis is placed
on keeping markets continuously informed about events to enable the investment community to value the company. Nutri Pharma
intends to achieve this by presenting results, publishing quarterly and annual reports, communication towards analysts and
financial media in addition to public disclosure of significant events.
Changed Financial Calendar 201005.03.2010 - Due to changed plan for Board Meetings in Nutri Pharma ASA the release of Q2 for 2010 is postponed from 26(th)
of August, to 31(st) of August 2010....
Approved supplemental prospectus26.02.2010 - Oslo Børs has approved following supplemental
prospectus:
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA
Supplemental prospectus
CORRECTION: FOURTH QUARTER AND PRELIMINARY 2009 RESULTS23.02.2010 - This is a correction of the announcement from 19:02 23.02.2010 CET. Reason for the correction: The attached file
appeared in zip-format for some receipients. Please see the Q4 report in a pdf-format instead....
FOURTH QUARTER AND PRELIMINARY 2009 RESULTS23.02.2010 - Turnover from sale to Nikken was for FY 2009 MNOK 14.1. Nikken topped up its inventories in conjunction with
the launch in May 2009...
Mandatory notification of trade22.01.2010 - KAG AS a company fully owned and controlled by Birger Sørensen CEO of Bionor Immuno AS (a subsidiary of Nutri
Pharma ASA), has has today purchased 90.000 NUT
shares at NOK 2.10 per share....
New Primary insiders in NUT 19 February 201019.02.2010 - Reference is made to the stock exchange notification published by 18 February 2010 regarding primary insiders
in Nutri Pharma ASA ("NUT")....
Approved prospectus19.02.2010 - NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA. Please
visit this link to access the prospectus.....
Commencement of subscription period for subsequent offering19.02.2010 - Reference is made to stock exchange notice 18
February 2010 regarding completion of private placement in Nutri Pharma ASA ("NUT" or the "Company") of 50 million shares
(the "Private Placement") as well as previous stock exchange notices....
Approved prospectus18.02.2010 - Offering and listing of up to 10,000,000 Subsequent Offering Shares each with a nominal value of NOK 0.25 in
connection with a repair offering to
Eligible Shareholders at a subscription price of NOK
2.00 raising total gross proceeds of up to NOK
20,000,000...
Share capital increase and registrations in the Norwegian Register of Business Enterprises18.02.2010 - Reference is made to the stock exchange notice of 12 February 2010 regarding the extraordinary general
meeting of Nutri Pharma ASA (the "Company"),.....
PRESS CONTACT For further information on Nutri Pharma, please contact CEO Trond Syvertsen on telephone +47 2331 0880 or send us an
e-mail
|
2006 Nutri Pharma ASA Telephone +47 23 01 09 60 Telefax +47 23 01 09 70
Contact Page
